Unknown

Dataset Information

0

Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection


ABSTRACT: The recombinant soluble human angiotensin-converting enzyme 2 (rshACE2) is a promising therapy against SARS-CoV-2 infection, but it has some drawbacks that reduce the success of its clinical applications. The bioengineered ACE2 (Tag-sACE2 and probiotic-ACE2) as a way may overcome its therapeutic limitations against ongoing current pandemic.

SUBMITTER: Maiti B 

PROVIDER: S-EPMC8589099 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7504743 | biostudies-literature
| S-EPMC7256354 | biostudies-literature
| S-EPMC8265022 | biostudies-literature
| S-EPMC7845504 | biostudies-literature
| S-EPMC8183004 | biostudies-literature
| S-EPMC7892319 | biostudies-literature
| S-EPMC7480804 | biostudies-literature
| S-EPMC7592753 | biostudies-literature
| S-EPMC7459545 | biostudies-literature